Chronic graft versus host disease
ORPHA: 999211 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| axatilimab Orphan Cold Chain | Oral capsule | FDA Approved (2024) | 1 | — |
Clinical Presentation
Signs and symptoms associated with Chronic graft versus host disease, sourced from HPO and Orphanet clinical annotations.
Poor wound healingThickened skinIntermittent generalized erythematous papular rashXerostomiaRecurrent corneal erosionsPhotophobiaAbnormality of skin pigmentationKeratoconjunctivitis siccaAlopeciaOnycholysisBronchiectasisRecurrent infectionsElevated circulating hepatic transaminase concentrationNail dystrophyErythemaFood intoleranceAbnormal vagina morphologyHematuriaMuscle weaknessArthritisFlexion contractureAscitesPhimosisWeight lossPancytopeniaDiarrheaDysphagiaNauseaGastroesophageal refluxAbdominal painAbnormal esophagus morphologyAnorexiaEsophageal strictureDyspneaPneumothoraxPulmonary infiltratesPleural effusionArthralgiaMyalgiaEsophageal ulcerationAirway obstructionBronchiolitis obliteransEntrapment neuropathyMorpheaPainCoughAbnormal esophagus physiologyWheezingFasciitisUrinary bladder inflammationChest painSkin vesicleSkin ulcer
Classification & Codes
Orphanet Code
ORPHA:99921Chronic graft versus host disease
| Orphanet | ORPHA:99921 |
| Treatments | 1 drug(s) |
| Symptoms on record | 53 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO